Looker Benjamin's Form 4 filing
Esperion Therapeutics, Inc. (ESPR) · filed Oct 20, 2025
- Accession no.
- 0001628280-25-045520
- Filed
- Oct 20, 2025
- Trade date
- Oct 17, 2025
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $3.27K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Looker BenjaminCIK 0001859509 | Officer (General Counsel) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 17, 2025 | Common Stock | SSaleDisposed | −1,248 | $2.62 | −$3,269.76 | 392,422 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.